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Probe-based confocal laser 
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Probe-based Confocal Laser Endomicroscopy (pCLE) is a powerful imaging technique that allows to 
perform gastrointestinal endomicroscopy at subcellular resolution. The aim of this study was to assess 
the use of pCLE to evaluate tumor angiogenesis in rectal and gastric cancers. A total of 35 consecutive 
patients with gastric and 91 with rectal carcinomas underwent endoscopy and pCLE during the same 
examination. Vascular assessment was based on vessel shape and size, vessel permeability and blood 
flow, and allowed the creation of an angiogenic score ranging from 0, for normal vasculature, to 4, 
for aberrant vasculature. A significant difference for the presence of vessels with large diameter and 
defective blood flow was found between rectal and gastric cancers. Overall, rectal cancers displayed a 
higher angiogenic score compared to gastric cancers. Conventional therapy induced a striking reduction 
in the angiogenic score only in rectal cancer patients. Taken together, our findings suggest that the 
pCLE technology is suitable for the evaluation of the tumor microvasculature abnormalities. Therefore, 
the real-time assessment of the vasculature status may represent a promising approach to predict 
the efficacy of the treatments and improve the clinical management of patients with gastric or rectal 
carcinomas.
Gastrointestinal (GI) cancer represents a major cause of morbidity and mortality, with incomplete response to 
chemotherapy in the advanced stages and poor prognosis1, 2.
The angiogenic switch is a crucial step in tumor progression where the balance between pro- and 
anti-angiogenic factors tilts toward the formation of new vessels to supply tumors with oxygen and nutrients for 
their relentless growth. The aberrant angiogenic stimuli within tumors leads to the formation of an abnormal 
vascular network characterized by dilated, tortuous, and hyper permeable vessels3–5 that diminish the efficacy of 
therapeutic treatments. Thus, evaluation of the tumor vascular pattern can provide vital information with a view 
to achieving a more accurate diagnosis and patient-tailored targeted treatment5. Recently, several studies have 
highlighted the importance of assessing the vascular pattern of gastric and rectal cancers in order to improve 
the accuracy determining the prognosis and establish the appropriate treatment6–9. Currently, immunohisto-
chemistry is a commonly used method in preclinical and clinical studies for assessing tumor vascularization and 
determining microvessel density. This method is time-consuming and involves invasive biopsy sampling to mon-
itor vascular changes over the treatment period10. Besides vascular density, other morphologic and functional 
parameters such as vessel diameter and shape, branching points and vessel permeability can be taken into account 
with tumor angiogenesis11–13.
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Probe-based Confocal Laser Endomicroscopy (pCLE) is an advanced endoscopic technique that can provide a 
dynamic real-time imaging of the mucosa at subcellular level14, 15. The visualization of the cellular and subcellular 
structures, as well as capillaries and single red blood cells, are peculiar characteristics of this novel GI endos-
copy method. High-resolution confocal imaging is achieved through i.v. injection of fluorescein16. This enables 
analysis not only of the vascular structure but also of the functionality, since the dye pours out of the abnormally 
formed vessels and the extent of the leakage can be determined. In fact, in a recent study, vessel permeability 
was evaluated with this approach in patients with ulcerative colitis17. This technique has also been used in a 
few studies to objectively evaluate the microvessel density in different neoplastic stages. Preliminary data of the 
microvessel density have been reported for biliary cancers at the liver hilum18, 19, for Barrett’s esophagus20, and 
for GI tumors21–23.
Based on this preliminary evidence, the intention of this study was to exploit this new promising imaging tool 
to analyze the angiogenic pattern in patients with gastric and rectal cancer. The aim was to provide, by means of 
a non-invasive technique, a prompt and accurate evaluation of the pattern and efficiency of intratumoral vessels 
which may be important for predicting the efficacy of chemotherapy.
Results
Definition of the “angiogenic score”. In this investigation we specifically focused the attention toward 
the vasculature pattern at the surface of the tumors. In all patients the blood vessels were clearly visible and well 
resolved by pCLE and it was possible to discriminate the typical aberrant features characterizing the tumor-as-
sociated blood vessels. The vascular architecture of all the vessels was abnormal, being mostly represented by 
enlarged, distorted and highly permeable microvessels with altered erythrocyte flow. The representative images 
reported in Fig. 1A clearly indicate the presence of dilated, large and tortuous vessels, as well as of leakage of 
fluorescein from the vessels into the highly vascularized tumoral tissue. These vessels are often characterized by 
a discountinuous and defective blood flow (see Video S1). A value of “1” was assigned for the presence of each 
parameter and a value of “0” for the absence. Based on these observations, we generated an “angiogenic score” 
ranging from 0 (normal vasculature) to 4 (extremely aberrant and non-functional vasculature) and representing 
the arithmetical sum of the single parameters as reported in Fig. 1B.
To assess the reliability of the angiogenic score we then compared vessel patterns identified with the pCLE 
analyses with the immunohistochemical analyses of the colon biopsies following CD31 staining. In a first set 
including 40 consecutive patients, pCLE images from 25 sequences in the same area of the biopsy sites were qual-
itatively compared to the CD31-stained vessels from the corresponding histological section. In Fig. 2, the images 
from the representative sequences obtained from three patients (#1 and #2, rectal; #3, gastric) by pCLE are com-
pared side by side with the corresponding CD31 immunohistological staining. The comparison showed a quali-
tative clear overlap between the results obtained through the immunohistological analysis and the morphological 
patterns assessed in real time by pCLE. Encouraged by these results the remaining patients with advanced-phase 
cancers were subjected to pCLE analysis.
Figure 1. Angiogenic score parameters. (A) Representative images obtained during pCLE endomicroscopy 
showing the presence of vessels’ leakage, tortuous vessels, and dilated, large blood vessels. (B) Table reporting 
the criteria used to generate the angiogenic score, i.e. through the arithmetical sum of the scores of the single 
parameters to which a value of 0 was assigned to indicate absence and of 1 to indicate presence.
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Angiogenic score in rectal and gastric cancers. The angiogenic score was assigned to every patient 
undergoing pCLE and none of the patients scored “0”, due to the fact that the tumors were locally advanced and 
that vasculature never appeared “normal”. An example of highly abnormal vasculature is shown in Fig. 3A. In this 
case, an angiogenic score of “4” was assigned to the tumor vasculature since all angiogenic parameters taken into 
account to measure the vessel abnormality were present. Moreover, more than one parameter could be detected 
in a single frame (see Fig. 3A, right and middle images). In this rectal cancer patient, the presence of aberrant 
vasculature was particularly evident, especially in terms of defects in blood flow, implying inefficient blood trans-
portation. In this clinical case we also observed an abundance of very irregular, tortuous and dilated vessels, 
characterized by uneven orientation with the adjacent tissue and by frequent regions of leakage (see Fig. 3A).
Taking into account both gastric and rectal cancer patients, the first observation was that the vasculature dif-
fered qualitatively in the two types of tumors, especially regarding the presence of aberrant blood flow. This was 
rarely detectable in gastric cancer, whereas it repeatedly occurred in the vessels of the rectal cancer in a statisti-
cally significant way (P < 0.01, see Fig. 3B). Also vessels with a large diameter were more frequent in rectal than 
in gastric cancer patients (P = 0.03, see Fig. 3B). The other two abnormalities taken into account were homogene-
ously distributed in both cancers (leakage, P = 0.76; tortuous vessels, P = 0.64).
Gastric and rectal cancers were found to be highly angiogenic since the score “1” was assigned to few cases 
in both tumor types (6% and 1%, respectively; see Fig. 3B). The percentage of the scores varied between the two 
tumors (P < 0.01). A striking difference could be observed for the highest score documented in 26% of the rectal 
Figure 2. CD31 immunohistological staining and pCLE imaging. Left panels: Representative images of the 
histological analysis of the tumor sections from three patients (rectal, patient #1 and #2; gastric, patient #3) 
using the anti-CD31 antibody to detect the blood vessels. Scale bar: 50 µm. Right panels: Representative pictures 
of the images obtained during the pCLE endoscopic analysis from the same patients.
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cancers and only in 3% of the gastric cancers (see Fig. 3B). Indeed, a higher angiogenic score was more frequently 
observed in rectal than in gastric cancer patients.
Angiogenesis score and tumor grading. A total of 110 patients underwent both pCLE analysis and 
endoscopic ultrasonography. These patients (35 gastric and 75 rectal cancers) were distributed into two categories 
(T2/T3N0, and TxN+) according to the presence or absence of lymph node infiltration (N0, no infiltration; N + , 
lymph node infiltration). As shown in Fig. S1, we only observed that the majority of the rectal cancers with lymph 
node infiltration (79.4%) were included in categories with high (3 and 4) angiogenic scores. Despite not being 
statistically significant and the need to examine a larger number of patients, this finding suggested that the eval-
uation of the aberrant features obtained through the pCLE analyses was associated more with tumor progression 
in rectal than in gastric cancer patients, where no association between angiogenic score and tumor grading was 
found at all.
pCLE in patients after radio/chemotherapy treatment. A total of 58 out of 126 patients completed 
the program of neoadjuvant radio/chemotherapy (47 with rectal and 11 with gastric cancer) corresponding to 
46% of the total number of patients (52% of total rectal and 31% of total gastric cancers) and were re-evaluated by 
pCLE. The evaluation of the vasculature after therapy (second pCLE) indicated an overall reduction of the angio-
genic score in almost all rectal cancer patients (see Fig. 4A–C). Indeed, only 4 patients (6%) were characterized by 
an increased angiogenic score and 10 (21%) displayed no changes (see Fig. 4A). pCLE results were in agreement 
with the standard endoscopy showing that a lower angiogenic score corresponded to a clear reduction of the 
tumoral area, whereas in the case of clinical progression an increased angiogenic score could be detected (data not 
shown). Interestingly, a superior score reduction was observed when in the first pCLE (before treatment) tumors 
were characterized by a high angiogenic score (4 or 3) (see Fig. 4A). Furthermore, unlike the presence of tortuous 
and large vessels and of aberrations of the blood flow which were significantly reduced after therapy, the presence 
of leaky vessels did not change (see Fig. 4G). No evident changes were detected in gastric cancers after therapy 
Figure 3. Angiogenic score in rectal and gastric cancers. (A) Representative images obtained from a rectal 
cancer patient displaying a high angiogenic score (4). In this patient all the altered features of tumor vasculature 
taken into account (leakage, tortuous and large vessels, and aberrant flow) were present. The white arrows 
indicate typical areas of discontinuous blood flow. (B) Table reporting the percentage of gastric and rectal 
cancer patients displaying the morphological and functional parameters mentioned above and the distribution 
of the angiogenic score among all rectal and gastric cancers analyzed. The presence of large vessels and defective 
flow was significantly more frequent in rectal than in gastric cancers.
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Figure 4. pCLE analysis after radio/chemotherapy. Graphs showing the angiogenic scores (A and D) and 
score distribution (B and F) assigned before (first pCLE) and after therapy (second pCLE) in 47 rectal and 11 
gastric cancer patients. Representative pCLE images collected from a patient affected by rectal (C) or gastric 
(E) cancer before and after therapy. (G) Table reporting the percentage of rectal cancer patients displaying the 
morphological and functional parameters taken into account to generate the angiogenic score assessed before 
and after therapy.
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(see Fig. 4D–F, and Table S2). In this case the vasculature displayed overall the same alterations detected before 
the treatment, indicating that the therapy did not affect angiogenesis in this type of tumor.
On-line and off-line evaluation of angiogenesis score. A first evaluation of angiogenic status was 
given in real time by the endoscopist during the pCLE analysis (on-line evaluation). Images were stored digitally 
and then reviewed with a dedicated software package. pCLE sequences were put into a random order and ana-
lyzed by a single investigator who was fully trained in confocal image interpretation and blinded to any clinical, 
endoscopical, or histopathological data (off-line evaluation). To verify the possibility of obtaining measurable 
information about the angiogenic status of the patients at the time of the endoscopy procedure, we then compared 
the given scores, considering three grades of concordance: “high” when the same score was assigned to a given 
patient; “medium” when the score differed by “1” and “low” when it differed by “2”. This approach was applied 
for all the pCLE analyses performed and for gastric and rectal cancers separately. A perfect (high) concordance 
was found in 33% of all endoscopies performed by pCLE whereas in 20% the concordance was low (see Fig. 5A). 
Although not statistically significant (P = 0.07) the percentage of low consistency obtained with the analysis of 
gastric cancers was higher (30%) than that obtained with the analyses of rectal cancers (16%), suggesting that 
the endoscopists were able to more consistently and properly evaluate the vascular network in this latter type of 
cancer (Fig. 5B).
Discussion
In this study, we explored the potential employment of pCLE for assessing the extent and quality of the tumor 
vascularization in two pathologic conditions of the GI tract. So far, the pCLE technique has been successfully 
employed for the detection of neoplastic Barrett’s esophagus24, 25, as well as for gastric and colorectal neopla-
sias26–28. These studies have demonstrated that the use of pCLE empowers the diagnosis with predictive informa-
tion leading to clinical benefits for the management of GI neoplasias. However, confocal imaging has the potential 
to go far beyond. The results obtained in this study suggest that this technique is exceptionally useful for visual-
izing tumor vasculature. As suggested by other authors, a non-invasive characterization of the tumor vessels may 
be useful for predicting the effects of the therapy and be of key importance for the development of personalized 
therapeutic interventions29, 30.
The use of pCLE for visualizing the angiogenic status of tumors could provide clinicians with fast and accurate 
information in contrast to the traditional conventional immunohistochemical approach. The present investiga-
tion is the first to take into account the analysis of tumor vasculature by pCLE in a considerable number of rectal 
and gastric cancers. Two recent studies showed that the use of confocal laser endomicroscopy in colorectal can-
cers was suitable for measuring more vascular parameters than conventional immunohistochemistry alone, and 
for detecting tumor neoangiogenesis with fluorescently labeled antibodies31, 32. The approach used by the authors 
was completely different: the pCLE analysis was not performed during the endoscopic examination but on fresh 
tumor biopsies. Moreover, in these studies only a very small number of colon cancer patients were enrolled for the 
analysis. Very few patients were also examined in another very recent study showing that pCLE could be a valid 
technique for assessing the microvascular networks in colorectal cancers during routine endoscopy33.
To quantify the grade of alteration of the tumor vasculature we decided to take into account the most impor-
tant features characterizing the tumor-associated vasculature that could also be easily detectable with pCLE. 
We previously reported that the alterations of the tumor vasculature could be useful for providing informa-
tion about the “angiogenic status” of the patients34. In the present study the analysis of a consistent number of 
patients allowed the generation of an “angiogenic score” based on the presence of vessel leakage, dilated (large) 
Figure 5. On-line and off-line evaluation of the angiogenesis score. (A) Graph representing the consistency 
between the on-line and off-line evaluations of the angiogenic score. “High” correlation was attributed to the 
cases where the same value was assigned during the on-line and off-line analysis section; “medium” correlation 
when the scores differed for “1” and “low” for “2”. (B) Correlation between the on-line and off-line evaluations 
for rectal and gastric cancers analyzed separately.
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and tortuous vessels and the presence of defective blood flow. To detect this last feature, the pCLE approach 
is indispensable since only a moving picture can record the back and forth flow of blood cells. Furthermore, 
endomicroscopy is also unique in its ability to dynamically visualize cellular processes in their native environ-
ment free of artifacts23, 35. Thus, given the extended possibilities offered by this new technique, we aimed to eval-
uate different vascular morphometric parameters in rectal and gastric cancers, which were previously difficult to 
achieve through conventional immunohistochemistry. We found that, although both advanced rectal and gastric 
cancers were highly angiogenic, the two tumor types were significantly different concerning the frequency of 
dilated vessels and the presence of defective flow, which were more detectable in the rectal tumor vasculature. 
As a consequence, the angiogenic score was generally higher in rectal than in gastric cancer. These results may 
entail two distinct consequences. On the one hand, the defective flow may profoundly affect the escape of tumor 
cells in the blood to invade new organs and thus the progression of the disease may be affected by distinct con-
tributions in the two tumor types. On the other side, the presence of a highly non-functional vasculature may 
jeopardize the therapeutic management of these tumors. It is in fact known that the delivery of chemotherapy 
can be highly compromised in the presence of an exceedingly abnormal vasculature36, 37. Only the normalization 
of these vessels, possibly through the employment of anti-angiogenic drugs, may make it possible to achieve 
more efficacious treatments for patients. Therefore, to be able to assess the extent and quality of the blood vessels 
within the tumors and also to monitor the possible modifications occurring during treatments, we conducted a 
preliminary evaluation using pCLE also after neoadjuvant radio- and/or chemotherapy. While in the majority of 
rectal cancer patients we detected a reduction of the angiogenic score after treatment, no substantial changes were 
documented in gastric cancers. The presence of leaky vessels did not change in general, possibly due to the inflam-
matory process activated by the therapy. The decrease of the angiogenic score in rectal cancers was indicative of 
an efficacious therapeutic intervention; on the other hand, the unchanged vascular alterations in gastric cancer 
patients correlated positively with stable or progressive disease. Indeed, since a small remission was detected in 
only 27% of gastric cancer patients (data not shown) it was possible that the unaltered angiogenic score could be 
ascribed to the lack of treatment efficacy. Based on these findings, it can be reasoned that, during the treatment 
schedule, pCLE analysis could be carried out to monitor the changes in the tumor vasculature induced by the 
treatments and possibly introduce anti-angiogenic drugs when necessary. Moreover, the analyses performed on 
gastric cancer patients suggest that these patients could especially benefit from neoadjuvant angiogenetic tai-
lored therapy, thereby improving also the efficacy of the standard therapy. A greater benefit with anti-angiogenic 
strategies had already been established for the humanized anti-VEGF-A monoclonal antibody bevacizumab. The 
antibody failed to yield an OS advantage as demonstrated in the international AVAGAST trial but enabled sig-
nificant improvements in progression-free survival (PFS) and response rate38. Two other recent trials (REGARD 
and RAINBOW) confirmed the survival advantage of the antiangiogenic agent ramucirumab, an antibody against 
VEGF-R2, used in second-line setting in gastric cancer39.
Our study shows that the angiogenic score may be applied during endomicroscopy with a moderate grade of 
“consistency”, at least for rectal cancer patients, thereby granting very rapid information on the vascularization 
pattern of a given patient. A lower concordance related to gastric cancer analyses could be due to the excess of 
fibrotic tissue in gastric tumors, which may render difficult the clear detection of the vascularized regions by 
pCLE in real-time. This problem is overcome by off-line evaluation since the dedicated software allows the images 
to be corrected and stabilized after digital storage. In any case, off-line evaluation can provide information more 
rapidly than histological procedures.
The evaluation of tumor vasculature may provide vital information for predicting the efficacy of treatments 
and for achieving tailored interventions for individual patients. Here we showed that pCLE is a valid method for 
real-time analysis of the vascular density and efficacy in gastric and rectal cancers. The results indicate that pCLE 
has the potential to generate a significant impact and there is a tangible possibility of translating the information 
gathered into clinical practice. By recording the morphological and “functional” characteristics of tumor vessels 
by assigning an angiogenic score to each patient during endoscopy, we could identify those patients who might 
benefit from anti-angiogenic therapy.
Materials and Methods
Patients. A total of 126 patients with locally advanced cancer in the majority of cases (35 had gastric cancer 
and 91 rectal carcinoma) who underwent pCLE endomicroscopy between January 2014 and April 2016 were 
consecutively enrolled. Written informed consent was obtained from each patient on the day of the procedure. 
The methodologies conformed to the standards set by the Declaration of Helsinki. This study was approved by the 
Institutional Board of CRO-IRCCS, National Cancer Institute of Aviano (PN), Italy (IRB no. CRO-2014-03). The 
clinical evaluations are reported in Table S1. Rectal cancer patients underwent the standard treatment for locally 
advanced rectal cancer (neoadjuvant radiation with concurrent fluoropyrimidin-based chemotherapy, followed 
by surgical resection including total mesorectal excision). Gastric cancer patients underwent neoadjuvant mul-
tiregimen chemoradiotherapy followed by surgical resection. Laboratory and pathological results were collected 
by means of the hospital database.
Endoscopy procedures and pCLE analyses. pCLE analyses were carried out with GastroFlex UHD 
probe (Cellvizio, Mauna Kea Technology, Paris, France) during gastroscopy and colonoscopy (Olympus series 
180). 110 patients also underwent endoscopic ultrasonography (Olympus series 160) immediately after pCLE 
analyses. Patients were examined before any radio/chemotherapeutic or surgical intervention (first pCLE). 58 
patients (corresponding to 46% of all patients) were also examined after treatment (second pCLE). Images and 
sequences of the normal and neoplastic mucosa were taken and the conventional bioptic samples obtained by 
macrobiopsy (COOK Medical, Ireland) at the end of the examination. Images were recorded within the first 
10 minutes following i.v. injection of fluorescein (5 ml of a 10% solution). pCLE images were collected at 12 frames 
www.nature.com/scientificreports/
8SCIENTIFIC REPoRTS | 7: 9819  | DOI:10.1038/s41598-017-10963-1
per second to ensure high video quality and a direct visualization on a single erythrocyte scale. pCLE recordings 
were carried out for 3 min resulting in a real-time imaging of more than 2000 frames. Using the videomosaicing 
function provided by the analysis software which enables the input frames to be aligned, we also obtained the 
reconstruction of the scanned panoramas of the mucosa. Through this technique we assessed: 1) the mucosal 
architecture; 2) the vascular density and vessel morphology; 3) the efficiency of the blood flow. Endoscopists pro-
vided an initial evaluation of the various angiogenic parameters in real time (on-line evaluation). The images were 
digitally stored and reviewed by a single investigator who is fully trained and proficient in confocal image inter-
pretation with the dedicated software package (Cellvizio Viewer, Mauna Kea Technologies), which also enables 
image correction and stabilization. This investigator was blinded to any clinical, endoscopical, or histopatholog-
ical information (off-line evaluation). The evaluation of the extent and quality of the intra-tumoral angiogenesis 
was determined based on the presence of tortuous and large sized vessels, the vessels’ leakage and the presence 
of defective flow. Surgical specimens were submitted for pathological examination. Sections were obtained from 
tumor lesions and analyzed by immunohistochemistry using an antibody specific for the endothelial marker 
CD31 (Clone JC70A, DakoCytomation, Italy) to visualize the vessels.
Statistical analysis. Fisher or McNemar tests were carried out to assess differences between frequencies, 
as appropriate. All tests were two-tailed and results were considered statistically significant for a p-value < 0.05.
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